Bio

Dr. Stephen Richmond (he/him/his) is a family physician, educator, and health justice advocate with specific interest in racial equity in medicine. He currently serves as a clinical assistant professor of medicine in the Division of Primary Care & Population Health (PCPH) in the Stanford Department of Medicine. He completed his A.S. at Solano Community College, B.A. in Molecular & Cell Biology at UC Berkeley, M.P.H. at Harvard T.H. Chan School of Public Health, and his M.D. at David Geffen School of Medicine, UCLA. He is a graduate of the UCSF-San Francisco General Hospital Family & Community Medicine Residency Program.

As a clinician, Dr. Richmond cares for individuals of all ages with a wide range of acute and chronic illnesses. He is especially passionate about providing high quality, evidenced-based care to underserved communities of color. As a researcher and educator, his interests broadly involve the intersection of race, racism, and medicine, with current projects focused on applications of Critical Race Theory to medical education and clinical care. He currently serves as the faculty director for the REACH Health Equity Scholarly Concentration within the school of Medicine and the Diversity, Equity, & Inclusion Curriculum Lead within the PCPH Division.

Beyond Stanford, Dr. Richmond is involved in many ongoing advocacy efforts aimed at achieving health equity through individual and structural-level change. Dr. Richmond has received multiple teaching awards for his work in the space of equity, inclusion & anti-oppression in medicine, and is a routine presenter and consultant in these areas.

Clinical Focus

  • Family Medicine

Academic Appointments

Administrative Appointments

  • REACH MedEd Section Lead, Stanford School of Medicine (2023 - Present)
  • PCPH DEI Curriculum Lead, Division of Primary Care & Population Health, Stanford Department of Medicine (2022 - Present)
  • Faculty Director, Reach Health Equity Scholarly Concentration, Stanford School of Medicine (2022 - Present)

Professional Education

  • Board Certification: American Board of Family Medicine, Family Medicine (2020)
  • Residency: UCSF Family Medicine Residency (2020) CA
  • Medical Education: UCLA David Geffen School Of Medicine Registrar (2017) CA
  • M.P.H, T.H. Chan School of Public Health, Harvard University, Health & Social Behavior (2016)
  • B.A., University of California, Berkeley, Molecular & Cell Biology (2012)
  • A.S., Solano Community College, Biology, Chemistry, General Science (2009)

Contact

  • Academic
    srichmond@stanford.edu
    University - Academic staff Department: Med/Primary Care and Population Health Position: Clinical Assistant Professor
  • Clinical (Primary)  Stanford Family Medicine 211 Quarry Rd Ste 405 MC 5985 Palo Alto, CA 94304 (650) 498-7750 (fax)

Additional Clinical Info

Additional Info

  • Mail Code: 5411

2024-25 Courses

All Publications

  • The Construction and Meaning of Race Within Hypertension Guidelines: A Systematic Scoping Review. Journal of general internal medicine Awolope, A., El-Sabrout, H., Chattopadhyay, A., Richmond, S., Hessler-Jones, D., Hahn, M., Gottlieb, L., Razon, N. 2024

    Abstract

    BACKGROUND: Professional society guidelines are evidence-based recommendations intended to promote standardized care and improve health outcomes. Amid increased recognition of the role racism plays in shaping inequitable healthcare delivery, many researchers and practitioners have critiqued existing guidelines, particularly those that include race-based recommendations. Critiques highlight how racism influences the evidence that guidelines are based on and its interpretation. However, few have used a systematic methodology to examine race-based recommendations. This review examines hypertension guidelines, a condition affecting nearly half of all adults in the United States (US), to understand how guidelines reference and develop recommendations related to race.METHODS: A systematic scoping review of all professional guidelines on the management of essential hypertension published between 1977 and 2022 to examine the use and meaning of race categories.RESULTS: Of the 37 guidelines that met the inclusion criteria, we identified a total of 990 mentions of race categories.Black and African/African American were the predominant race categories referred to in guidelines (n=409). Guideline authors used race in five key domains: describing the prevalence or etiology of hypertension; characterizing prior hypertension studies; describing hypertension interventions; social risk and social determinants of health; the complexity of race. Guideline authors largely used race categories as biological rather than social constructions. None of the guidelines discussed racism and the role it plays in perpetuating hypertension inequities.DISCUSSION: Hypertension guidelines largely refer to race as a distinct and natural category rather than confront the longstanding history of racism within and beyond the medical system.Normalizing race as a biological rather than social construct fails to address racism as a key determinant driving inequities in cardiovascular health. These changes are necessary to produce meaningful structural solutions that advance equity in hypertension education, research, and care delivery.

    View details for DOI 10.1007/s11606-024-08874-9

    View details for PubMedID 38954319

  • How Abolition of Race-Based Medicine Is Necessary to American Health Justice. AMA journal of ethics Richmond Ii, S. P., Grubbs, V. 2022; 24 (3): E226-232

    Abstract

    Modern medicine has always endorsed White supremacy by maintaining social, political, and economic structures that have exacerbated Black and Brown persons' lived embodiment of racism. Racial essentialism persists in health professions education and practice, especially in kidney disease etiology and intervention. This article considers how glomerular filtration rate estimates are one example of historically, politically, and scientifically situated racialized practice in health care today that illuminates a glaring need to abolish race-based clinical care of any kind.

    View details for DOI 10.1001/amajethics.2022.226

    View details for PubMedID 35325524

  • A MULTI-SITE MIXED-METHODS STUDY OF DE-IMPLEMENTING RACE-BASED EGFR REPORTING Kostelanetz, S., Kripalani, S., Audet, C., Umeukeje, E. M., Nair, D., Hoenig, M., Mendu, M., Hahn, M., Richmond, S., Young, B., Manos, A., Bonnet, K., Schlundt, D., Morse, M., Wilkins, C., Eneanya, N., Roumie, C. L. SPRINGER. 2021: S54

    View details for Web of Science ID 000679443300128